BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Radiology (2003) 76, S81-S82
© 2003 British Institute of Radiology
doi: 10.1259/bjr/42249357
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dzik-Jurasz, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dzik-Jurasz, A

Full Paper

Angiogenesis imaging in man: a personal view from the pharmaceutical industry

A Dzik-Jurasz, PhD, FRCS, FRCR

Translational Medicine and Technology, GlaxoSmithKline, Greenford, UK

Correspondence: Dr A Dzik-Jurasz, GlaxoSmithKline, 891-995 Greenford Road, Greenford, Middlesex UB6 0HE, UK. e-mail: andrzej.s.dzik-jurasz@gsk.com

The imaging of angiogenesis in human disease represents an exciting prospect for those involved in the drug development process. With an increasing focus on the therapeutic modulation of angiogenesis in man, the development of technologies capable of monitoring angiogenic drug interventions non-invasively should be welcomed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2003 by the British Institute of Radiology.